Invention Grant
- Patent Title: Anti-human interleukin-17A monoclonal antibody
-
Application No.: US16309072Application Date: 2017-06-09
-
Publication No.: US10738112B2Publication Date: 2020-08-11
- Inventor: Chenghai Zhang , Lingqiao Zhu , Jinlin Guo , Jie Zhao , Honghai Gao , Lin Ma , Wei Dang , Yan Yang
- Applicant: SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
- Applicant Address: CN Shanghai
- Assignee: SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
- Current Assignee: SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
- Current Assignee Address: CN Shanghai
- Agency: Greer, Burns & Crain, Ltd.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@469c7b43
- International Application: PCT/CN2017/087733 WO 20170609
- International Announcement: WO2017/215524 WO 20171221
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61P17/00 ; A61P25/00 ; A61P17/06 ; A61P27/02 ; A61P37/02 ; A61P29/00 ; A61P19/02 ; A61P11/06 ; A61P19/08 ; A61P37/06 ; C12N15/85 ; A61K38/00
Abstract:
An anti-human IL-17A monoclonal antibody, the preparation method, and the use thereof are provided. The anti-human IL-17A monoclonal antibody can specifically bind to human IL-17A and has a good effect for inhibiting the secretion of inflammatory cytokines, such as IL-6 and the like by means of various cell lines induced by IL-17A, and can be used for preparing drugs for treating diseases involving immune-medicated inflammatory responses.
Public/Granted literature
- US20190161544A1 ANTI-HUMAN INTERLEUKIN-17A MONOCLONAL ANTIBODY, AND PREPARATION METHOD AND USE THEREOF Public/Granted day:2019-05-30
Information query
